Best's macular dystrophy (BMD), a disease with many similarities to age-related macular degeneration (AMD). AMD is the leading cause of blindness in the western world and is currently untreatable. By understanding how mutations in bestrophin cause BMD we will gain insights into the causes of AMD with the expectation that the knowledge gained will lead to effective therapies for this disease. A distinguishing symptom of BMD is a depressed light response in the electro-oculogram without alterations in the electro-retinogram, a condition mimicked by the toxic responses induced by ocular iron overload, and drugs that affect iron metabolism. Thus the studies outlined in this proposal are designed to determine a function for bestrophin guided by the hypothesis that bestrophin is involved in the regulation of iron homeostasis or transcytotic transport by the retinal pigment epithelium (RPE). This hypothesis is reinforced by the presence of several potential iron binding motifs in the amino acid sequence of bestrophin.
Specific aims focus on: The subcellular localization and developmental expression of bestrophin; determination of bestrophin function in vitro; determination of bestrophin function in vivo; and biochemical characterization of bestrophin. The localization of bestrophin will be determined by immunofluorescence microscopy using antibodies raised against bestrophin, or bestrophin fused with green fluorescent protein. The function of bestrophin will be tested in assays of iron binding, ferroxidase/ferrireductase activity, and transport and uptake of iron by the RPE. The effects of mutant bestrophin on the phagocytic pathway of RPE cells, such as delayed kinetics of outer segment degradation and altered pH of endosomal/phagosomal compartments will be tested. BMD associated mutants of bestrophin will be expressed in the RPE of mice and rats using adenovirus mediated gene transfer, followed by histologic, electrophysiologic, and biochemical analysis of the effects on lipofuscin accumulation and retinoid processing.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
1R01EY013160-01
Application #
6191430
Study Section
Visual Sciences C Study Section (VISC)
Program Officer
Dudley, Peter A
Project Start
2000-09-01
Project End
2004-08-31
Budget Start
2000-09-01
Budget End
2001-08-31
Support Year
1
Fiscal Year
2000
Total Cost
$346,000
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Stanton, James B; Marmorstein, Alan D; Zhang, Youwen et al. (2017) Deletion of Efemp1 Is Protective Against the Development of Sub-RPE Deposits in Mouse Eyes. Invest Ophthalmol Vis Sci 58:1455-1461
Zhang, Youwen; Cross, Samuel D; Stanton, James B et al. (2017) Early AMD-like defects in the RPE and retinal degeneration in aged mice with RPE-specific deletion of Atg5 or Atg7. Mol Vis 23:228-241
Dalvin, Lauren A; Pulido, Jose S; Marmorstein, Alan D (2017) Vitelliform dystrophies: Prevalence in Olmsted County, Minnesota, United States. Ophthalmic Genet 38:143-147
Johnson, Adiv A; Guziewicz, Karina E; Lee, C Justin et al. (2017) Bestrophin 1 and retinal disease. Prog Retin Eye Res 58:45-69
Marmorstein, Alan D; Kinnick, Tyson R; Stanton, J Brett et al. (2015) Bestrophin-1 influences transepithelial electrical properties and Ca2+ signaling in human retinal pigment epithelium. Mol Vis 21:347-59
Johnson, Adiv A; Bachman, Lori A; Gilles, Benjamin J et al. (2015) Autosomal Recessive Bestrophinopathy Is Not Associated With the Loss of Bestrophin-1 Anion Channel Function in a Patient With a Novel BEST1 Mutation. Invest Ophthalmol Vis Sci 56:4619-30
Lee, Yong S; Marmorstein, Lihua Y; Marmorstein, Alan D (2014) Soluble adenylyl cyclase in the eye. Biochim Biophys Acta 1842:2579-83
Johnson, Adiv A; Lee, Yong-Suk; Chadburn, Andrew J et al. (2014) Disease-causing mutations associated with four bestrophinopathies exhibit disparate effects on the localization, but not the oligomerization, of Bestrophin-1. Exp Eye Res 121:74-85
Johnson, Adiv A; Lee, Yong-Suk; Stanton, J Brett et al. (2013) Differential effects of Best disease causing missense mutations on bestrophin-1 trafficking. Hum Mol Genet 22:4688-97
Cui, Chang-Yi; Childress, Victoria; Piao, Yulan et al. (2012) Forkhead transcription factor FoxA1 regulates sweat secretion through Bestrophin 2 anion channel and Na-K-Cl cotransporter 1. Proc Natl Acad Sci U S A 109:1199-203

Showing the most recent 10 out of 46 publications